Randomized Controlled Trial
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 28, 2014; 20(32): 11406-11414
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11406
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Lipid peroxidation (thiobarbituric acid reactive substances). A: In the gut; B: In the lungs. TBARS: Thiobarbituric acid reactive substances; SO: Control group means. I/R: Ischemia/reperfusion.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Levels of superoxide dismutase. A: In the gut; B: In the lungs. SOD: Superoxide dismutase; SO: Control group means. I/R: Ischemia/reperfusion.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Immunohistochemical expression of nuclear factor kappa beta. A: In the gut; B: In the lungs. SO: Control group means; I/R: Ischemia/reperfusion; NF-κB: Nuclear factor kappa beta.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Digital images of the immunohistochemical expression of nuclear factor kappa beta (photomicrography, × 200). A: Ischemia/reperfusion (I/R) gut; B: G + I/R gut; C: I/R lung; D: G + I/R lung.
Figure 5
Open in New Tab Full Size Figure Download Figure
Figure 5 Immunohistochemical expression of interleukin-6. A: In the gut; B: In the lungs. SO: Control group means; I/R: Ischemia/reperfusion; IL: Interleukin.
Figure 6
Open in New Tab Full Size Figure Download Figure
Figure 6 Digital images of the immunohistochemical expression of interleukin-6 (photomicrography, × 200). A: Ischemia/reperfusion (I/R) gut; B: G + I/R gut; C: I/R lung; D: G + I/R lung.